Quantitative analysis of the packaging capacity of recombinant adeno-associated virus

Human Gene Therapy

Volumn 7, Issue 17, 1996, Pages 2101-2112

  Dong, Jian Yun ^a   Fan, Pei Dong ^a   Frizzell, Raymond A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; COMPLEMENTARY DNA; TRANSCRIPTION FACTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADENO ASSOCIATED VIRUS; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA CONTENT; DNA PACKAGING; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; REPORTER GENE; RESPIRATORY EPITHELIUM; VIRION; VIRUS PARTICLE; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS; FELIS CATUS;

EID: 0029849257     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.17-2101     Document Type: Article

References (44)

1. BANTEL-SCHAAL, U., and ZURHAUSEN, H. (1984). Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology 134, 52-63.
2. BEATON, A., PALUMBO, P., and BERNS, K.I. (1989). Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J. Virol. 63, 4450-4454.
3. BERNS, K.I. (1990). Parvovirus replication. Microbiol. Rev. 54, 316-329.
4. BERNS, K.I., KOTIN, R.M., and LABOW, M.A. (1988). Regulation of adeno-associated virus DNA replication. Biochim. Biophys. Acta 951, 425-429.
5. BLACKLOW, N.R., HOGGAN, M.D., and ROWE, W.P. (1968). Serological evidence for human infection with adenovirus-associated viruses. J. Natl. Cancer Inst. 40, 319-327.
6. BUCHMAN, A.R., and BERG, P. (1988). Comparison of intron-dependent and intron-independent gene expression. Mol. Cell. Biol. 8, 4395-4405.
7. CARTER, B.J. (1992). Adeno-associated virus vectors. Curr. Opin. Biotechnol. 3, 533-539.
8. FERRARI, F., SAMULSKI, T., SHENK, T., and SAMULSKI, R. (1996). Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234.
9. FISHER, K.J., GAO, G.P., WEITZMAN, M.D., DEMATTEO, R., BURDA, J.F., and WILSON, J.M. (1996). Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520-532.
10. FLOTTE, T.R., AFIONE, S.A., CONRAD, C., McGRATH, S.A., SOLOW, R., OKA, H., ZEITLIN, P.L., GUGGINO, W.B., and CARTER, B.J. (1993a). Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90, 10613-10617.
11. FLOTTE, T.R., AFIONE, S.A., SOLOW, R., DRUMM, M.L., MARKAKIS, D., GUGGINO, W.B., ZEITLIN, P.L., and CARTER, B.J. (1993b). Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268, 3781-3790.
12. GIRAUD, C., WINOCOUR, E., and BERNS, K.I. (1995). Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J. Virol. 69, 6917-6924.
13. GRAHAM, F.L., and PREVEC, L. (1991). Manipulation of Adenovirus Vectors. In Methods in Molecular Biology. (The Humana Press Inc., Clifton, NJ) pp. 109-127.
14. HERMONAT, P.L., and MUZYCZKA, N. (1984). Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc. Natl. Acad. Sci. USA 81, 6466-6470.
15. HOGGAN, M.D., BLACKLOW, N.R., and ROWE, W.P. (1966). Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc. Natl. Acad. Sci. USA 55, 1457-1471.
16. IM, D.S., and MUZYCZKA, N. (1989). Factors that bind to adeno-associated virus terminal repeats. J. Virol. 63, 3095-3104.
17. KAYE, J.F., and LEVER, A.M. (1996). Trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1. J. Virol. 70, 880-886.
18. KEARNS, W.G., AFIONE, S.A., FULMER, S.B., PANG, M.G., ERIKSON, D., EGAN, M., LANDRUM, M., FLOTTE, T.R., and CUTTING, G.R. (1996). Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. (in press).
19. KOTIN, R.M., SINISCALCO, M., SAMULSKI, R.J., ZHU, X.D., HUNTER, L., LAUGHLIN, C.A., MCLAUGHLIN, S., MUZYCZKA, N., ROCCHI, M., and BERNS, K.I. (1990). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 87, 2211-2215.
20. KOTIN, R.M., LINDEN, R.M., and BERNS, K.I. (1992). Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11, 5071-5078.
21. LABOW, M.A., and BERNS, K.I. (1988). The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in COS-7 cells. J. Virol. 62, 1705-1712.
22. LABOW, M.A., HERMONAT, P.L., and BERNS, K.I. (1986). Positive and negative autoregulation of the adeno-associated virus type 2 genome. J. Virol. 60, 215-258.
23. LAUGHLIN, C.A., TRATSCHIN, J.D., COON, H., and CARTER, B.J. (1983). Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23, 65-73.
24. LEBKOWSKI, J.S., McNALLY, M.M., OKARMA, T.B., and LERCH, L.B. (1988). Adeno-associated virus: A vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol. Cell. Biol. 8, 3988-3996.
25. MACGREGOR, G.R., and CASKEY, C.T. (1989). Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res. 17, 2365.
26. MANIATIS, T., FRITSCH, E.F., and SAMBROOK, J. (1982). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 16-64.
27. McLAUGHLIN, S.K., COLLIS, P., HERMONAT, P.L., and MUZYCZKA, N. (1988a). Adeno-associated virus general transduction vectors: Analysis of proviral structures. J. Virol. 62, 1963-1973.
28. McLAUGHLIN, S.K., COLLIS, P., HERMONAT, P.L., and MUZYCZKA, N. (1988b). Adeno-associated virus general transduction vectors: Analysis of proviral structures. J. Virol. 62, 1963-1973.
29. MENDELSON, E., SMITH, M.G., and CARTER, B.J. (1988). Expression and rescue of a nonselected marker from an integrated AAV vector. Virology 166, 154-165.
30. MESNARD, J.M., and CARRIERE, C. (1995). Comparison of packaging strategy in retroviruses and pararetroviruses. Virology 213, 1-6.
31. MUZYCZKA, N. (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Topics Microbiol. Immunol. 158, 97-129.
32. MYERS, M.W., and CARTER, B.J. (1980). Assembly of adeno-associated virus. Virology 102, 71-82.
33. PODSAKOFF, G., WONG, K.K., JR., and CHATTERJEE, S. (1994). Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol. 68, 5656-5666.
34. PREVEC, L., SCHNEIDER, M., ROSENTHAL, K.L., BELBECK, L.W., DERBYSHIRE, J.B., and GRAHAM, F.L. (1989). Use of human adenovirus-based vectors for antigen expression in animals. [Published erratum appears in J. Gen. Virol. 70, 2539, 1989.] J. Gen. Virol. 70, 429-434.
35. RICHARSON, W.D., and WESTPHAL, H. (1981). A cascade of adenovirus early functions is required for expression of adeno-associated virus. Cell 27, 133-141.
36. RICHARDSON, W.D., and WESTPHAL, H. (1984). Requirement for either early region 1a or early region 1b adenovirus gene products in the helper effect for adeno-associated virus. J. Virol. 51, 404-410.
37. RIORDAN, J.R., ROMMENS, J.M., KEREM, B.-S., ALON, N., ROZMAHEL, R., GRZELCZAK, Z., LOK, S., PLAVSIC, N., CHOU, J.-L., DRUMM, M.L., IANNUZZI, M., COLLINS, F.S., and TSUI, L.-C. (1989). Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245, 1066-1072.
38. RUFFING, M., ZENTGRAF, H., and KLEINSCHMIsT, J.A. (1992). Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J. Virol. 66, 6922-6930.
39. SAMULSKI, R.J., SRIVASTAVA, A., BERNS, K.I., and MUZYCZKA, N. (1983). Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell 33, 135-143.
40. SAMULSKI, R.J., CHANG, L.S., and SHENK, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63, 3822-3828.
41. SAMULSKI, R.J., ZHU, X., XIAO, X., BROOK, J.D., HOUSMAN, D.E., EPSTEIN, N., and HUNTER, L.A. (1991). Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10, 3941-3950.
42. SRIVASTAVA, A., LUSBY, E.W., and BERNS, K.I. (1983). Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45, 555-564.
43. TOUNEKTI, N., MOUGEL, M., ROY, C., MARQUET, R., DARLIX, J.L., PAOLETTI, J., EHRESMANN, B., and EHRESMANN, C. (1992). Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA. J. Mol. Biol. 223, 205-220.
44. WEIDEN, M.D., and GINSBERG, H.S. (1994). Deletion of the E4 region of the genome produces adenovirus DNA concatemers. Proc. Natl. Acad. Sci. USA 91, 153-157.